Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal‐ and luminal‐like breast cancer xenografts

Several clinical trials have investigated the efficacy of bevacizumab in breast cancer, and even if growth inhibiting effects have been registered when antiangiogenic treatment is given in combination with chemotherapy no gain in overall survival has been observed. One reason for the lack of overall...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Oncol
Hlavní autoři: Lindholm, Evita M., Kristian, Alexandr, Nalwoga, Hawa, Krüger, Kristi, Nygård, Ståle, Akslen, Lars A., Mælandsmo, Gunhild M., Engebraaten, Olav
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2012
Témata:
Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528356/
https://ncbi.nlm.nih.gov/pubmed/22521242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2012.03.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky